EXAS Jan 2026 62.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 01:20PM EDT
Loading interactive chart…
- Zacks
Why Is Exact Sciences (EXAS) Down 17.5% Since Last Earnings Report?
Exact Sciences (EXAS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Simply Wall St.
Exact Sciences (NASDAQ:EXAS) shareholders have endured a 63% loss from investing in the stock three years ago
If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But...
- Insider Monkey
Is Exact Sciences Corporation (NASDAQ:EXAS) the Gene Therapy Stock with the Greatest Potential?
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Exact Sciences Corporation (NASDAQ:EXAS) is the gene therapy stock with the greatest potential. Gene therapy involves treating illnesses by modifying, replacing, or supplementing faulty or missing genes responsible for a disease. This approach […]
© 2024 Yahoo. All rights reserved.